Mapping the global research landscape on depression for patients with chronic kidney disease: a bibliometric and visualized analysis from 2006 to 2022

Wenchao Xu, Zitong Chen, Yurong Zhang, Jiayu Zhao, Wenyong Huang, Xiaozhong Guo, Jianyu ZhangFrontiers in Pharmacology 2024 · DOI

Abstract

This bibliometric analysis offers an in-depth view of the research trajectory in Chronic Kidney Disease (CKD) and depression. It provides valuable insights for researchers seeking relevant literature, potential collaborators, and an understanding of the field's current hotspots and emerging frontiers. The findings of this study are instrumental in guiding and enriching future research endeavors in this domain.

The Clinical Intersection of CKD and Depression

Chronic Kidney Disease (CKD) is a global health challenge affecting over 10% of the population. Beyond physical complications, depression is a frequent and debilitating companion, affecting approximately 20% of CKD patients. This psychological burden significantly increases mortality risk and reduces treatment adherence, yet the research landscape has historically been fragmented. This study employs bibliometric analysis to provide a quantitative "map" of how this field has evolved over the last 16 years.

Methodology and Data Selection

The researchers conducted a systematic search of the Web of Science Core Collection (WoSCC) for articles published between 2006 and 2022. To ensure a focus on original research, the team applied rigorous exclusion criteria, filtering out non-English papers, review articles, and editorial materials.

Flowchart of the systematic data collection and retrieval strategy from the Web of Science database.

The final corpus consisted of 2,409 articles involving 12,761 authors. Analysis was performed using three primary tools: bibliometrix for quantitative scientometrics, VOSviewer for visual network mapping of collaborations, and CiteSpace to identify "citation bursts" that signal emerging research frontiers.

The analysis reveals a massive 548% surge in research activity over the study period. While publication volume remained relatively stagnant (under 100 papers per year) until 2013, the field reached a critical inflection point in 2014. Since then, research has entered a period of rapid growth, peaking at 305 articles in 2022.

Annual publication volume and growth trends of research on CKD and depression from 2006 to 2022.

This trend suggests a global shift in nephrology toward a more holistic, "biopsychosocial" view of patient care, recognizing that mental health is as critical as physical kidney function.

Geopolitical and Institutional Contributions

The United States and China are the primary drivers of this discourse. The US leads in both volume (31.7% of papers) and impact, with approximately 30,000 citations. While China ranks second in volume, its citation impact is significantly lower, suggesting a need for higher-quality output from emerging research hubs.

At the institutional level, the University of Pittsburgh and George Washington University lead in productivity. Individually, Paul L. Kimmel emerged as the most influential figure, bridging the gap between biological CKD research and psychological patient adaptation.

Thematic Shifts: From Survival to Quality of Life

Keyword analysis reveals a significant thematic evolution. Early research focused heavily on "mortality" and "prevalence." However, the field is moving toward "quality-of-life," "hemodialysis," and "anxiety." This indicates that researchers are shifting from merely identifying the problem to seeking ways to improve the daily lived experience of patients.

Limitations and Future Directions

While comprehensive, this study is limited by its reliance on a single database (Web of Science) and its exclusion of non-English articles. Future research should aim for broader international collaboration, particularly with underrepresented regions like Africa and the Middle East, to develop targeted therapies addressing the bidirectional link between kidney function and mental health.

Summary updated

Abstract

This bibliometric analysis offers an in-depth view of the research trajectory in CKD and depression. It provides valuable insights for researchers seeking relevant literature, potential collaborators, and an understanding of the field's current hotspots and emerging frontiers. The findings of this study are instrumental in guiding and enriching future research endeavors in this domain.
BibTeX
@inproceedings{xu2024mapping,
  author = {Wenchao Xu and Zitong Chen and Yurong Zhang and Jiayu Zhao and Wenyong Huang and Xiaozhong Guo and Jianyu Zhang},
  title = {{Mapping the global research landscape on depression for patients with chronic kidney disease: a bibliometric and visualized analysis from 2006 to 2022}},
  booktitle = {Frontiers in Pharmacology},
  year = {2024},
  doi = {10.3389/fphar.2024.1388641},
}
Figure